Christian Ortega Loubon

Dr. Christian Ortega Loubon

Hospital Clinic, Barcelona, Catalonia, Spain
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2016 in Annals of Cardiac Anaesthesia
Verified
Journal Article
Open access
PDF file
Christian Ortega LoubonChristian Ortega Loubon
Christian Ortega Loubon
MFManuel Fernández-Molina
Manuel Fernández-Molina
YCYolanda Carrascal
Yolanda Carrascal
EFEnrique Fulquet-Carreras
Enrique Fulquet-Carreras
Cardiac surgery-associated acute kidney injury (CSA-AKI) is a well-recognized complication resulting with the higher morbid-mortality after cardiac surgery. In its most severe form, it increases the odds ratio of operative mortality 3–8-fold, length of stay in the Intensive Care Unit and hospital, and costs of care. Early diagnosis is critical for an optimal treatment of this complication. Just as the identification and correction of preoperative risk factors, the use of prophylactic measures during and after surgery to optimize renal function is essential to improve postoperative morbidity and mortality of these patients. Cardiopulmonary bypass produces an increased in tubular damage markers. Their measurement may be the most sensitive means of early detection of AKI because serum creatinine changes occur 48 h to 7 days after the original insult. Tissue inhibitor of metalloproteinase-2 and insulin-like growth factor-binding protein 7 are most promising as an early diagnostic tool. However, the ideal noninvasive, specific, sensitive, reproducible biomarker for the detection of AKI within 24 h is still not found. This article provides a review of the different perspectives of the CSA-AKI, including pathogenesis, risk factors, diagnosis, biomarkers, classification, postoperative management, and treatment. We searched the electronic databases, MEDLINE, PubMed, EMBASE using search terms relevant including pathogenesis, risk factors, diagnosis, biomarkers, classification, postoperative management, and treatment, in order to provide an exhaustive review of the different perspectives of the CSA-AKI.

4 February 2019 in Diabetes/Metabolism Research and Reviews
Verified
Journal Article
Closed access
PDF file
Christian Ortega LoubonChristian Ortega Loubon
Christian Ortega Loubon
MFManuel Fernández‐Molina
Manuel Fernández‐Molina
GSGauri Singh
Gauri Singh
RCRicardo R. Correa
Ricardo R. Correa

1 June 2019 in The Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
Christian Ortega LoubonChristian Ortega Loubon
Christian Ortega Loubon
MFManuel Fernández-Molina
Manuel Fernández-Molina
ILInmaculada Fierro Lorenzo
Inmaculada Fierro Lorenzo
PJPablo Jorge-Monjas
Pablo Jorge-Monjas
YCYolanda Carrascal
Yolanda Carrascal
ETEduardo Tamayo
Eduardo Tamayo

14 December 2019 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Christian Ortega LoubonChristian Ortega Loubon
Christian Ortega Loubon
Francisco Herrera-GómezFrancisco Herrera-Gómez
Francisco Herrera-Gómez
CBCoralina Bernuy-Guevara
Coralina Bernuy-Guevara
PJPablo Jorge-Monjas
Pablo Jorge-Monjas
CSCarlos Ochoa Sangrador
Carlos Ochoa Sangrador
F. JAVIER ALVAREZF. JAVIER ALVAREZ
F. JAVIER ALVAREZ
Goal-directed therapy based on brain-oxygen saturation (bSo2) is controversial and hotly debated. While meta-analyses of aggregated data have shown no clinical benefit for brain near-infrared spectroscopy (NIRS)-based interventions after cardiac surgery, no network meta-analyses involving both major cardiac and noncardiac procedures have yet been undertaken. Randomized controlled trials involving NIRS monitoring in both major cardiac and noncardiac surgery were included. Aggregate-level data summary estimates of critical outcomes (postoperative cognitive decline (POCD)/postoperative delirium (POD), acute kidney injury, cardiovascular events, bleeding/need for transfusion, and postoperative mortality) were obtained. NIRS was only associated with protection against POCD/POD in cardiac surgery patients (pooled odds ratio (OR)/95% confidence interval (CI)/I2/number of studies (n): 0.34/0.14–0.85/75%/7), although a favorable effect was observed in the analysis, including both cardiac and noncardiac procedures. However, the benefit of the use of NIRS monitoring was undetectable in Bayesian network meta-analysis, although maintaining bSo2 > 80% of the baseline appeared to have the most pronounced impact. Evidence was imprecise regarding acute kidney injury, cardiovascular events, bleeding/need for transfusion, and postoperative mortality. There is evidence that brain NIRS-based algorithms are effective in preventing POCD/POD in cardiac surgery, but not in major noncardiac surgery. However, the specific target bSo2 threshold has yet to be determined.

22 October 2019 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Christian Ortega LoubonChristian Ortega Loubon
Christian Ortega Loubon
MMMaría Fe Muñoz-Moreno
María Fe Muñoz-Moreno
IGIrene Andrés García
Irene Andrés García
F. JAVIER ALVAREZF. JAVIER ALVAREZ
F. JAVIER ALVAREZ
EGEsther Gómez-Sánchez
Esther Gómez-Sánchez
MHMaría Heredia-Rodríguez
María Heredia-Rodríguez
Major changes have occurred in the epidemiology and etiology of infective endocarditis (IE). Nevertheless, the differences between nosocomial infective endocarditis (NIE) and community-acquired infective endocarditis (CIE) have not been addressed in a population-based study. We conducted a retrospective, nationwide, temporal trend study from 1997 to 2014 analyzing the epidemiology, clinical, geographical, meteorological characteristics of patients diagnosed with IE in Spain, to distinguish NIE from CIE. Among 25,952 patients with IE (62.2 ± 18·6 years; 65.9% men), 45.9% had NIE. The incidence of IE increased from 2.83 to 3.73 due to the NIE incidence increment with a decline in CIE. Patients with NIE were older (63.8 years vs. 60.8 years, p < 0·001), presented a higher Charlson index (1.22 vs. 1.03, p < 0.001), a greater history of implanted cardiac devices (8.7% vs. 4.6%, p < 0.001), and higher mortality (31.5% vs. 21.7%, p < 0.001). The most frequent microorganism for both NIE and CIE was Staphylococcus (p < 0.001), and the North reported a higher incidence (p < 0.001). Risk factors of mortality for NIE were age, Charlson index, hemodialysis, shock, heart failure, and stroke. Risk factors for CIE included female sex, renal disease, and cardiac-device carriers. The etiology of IE shifted from community origins to mostly nosocomial-associated infections. Higher morbidity, mortality, and poorer outcomes are associated with NIE.

1 January 2018 in Brazilian Journal of Cardiovascular Surgery
Verified
Journal Article
Open access
Christian Ortega LoubonChristian Ortega Loubon
Christian Ortega Loubon
MFManuel Fernández-Molina
Manuel Fernández-Molina
LPLucía Pañeda-Delgado
Lucía Pañeda-Delgado
PJPablo Jorge-Monjas
Pablo Jorge-Monjas
YCYolanda Carrascal
Yolanda Carrascal
The aims of this study were to identify the risk factors associated with acute kidney injury (AKI) after isolated surgical revascularization with cardiopulmonary bypass and to develop a model to predict the appearance of postoperative AKI. A total of 435 adult patients who underwent primary isolated coronary artery bypass graft (CABG) surgery, from 2012 to 2016, in the Clinic University Hospital of Valladolid (Spain) were enrolled. AKI was defined according to the risk, injury, failure, loss, and end-stage (RIFLE) criteria. Data were collected from hospital electronic medical records. Multiple logistic regression analysis was used to identify risk factors. The prevalence of AKI was 12.4%. Multivariate analysis identified age (odds ratio [OR], 1.056; 95% confidence interval [CI], 1.016-1.098; P=0.005), hypertension (OR, 3.078; 95% CI, 1.151-8.230; P=0.018), low ejection fraction (EF) (OR, 6.785; 95% CI, 2.080-22.135; P=0.001), estimated glomerular filtration rate (eGFR) (OR, 1.017; 95% CI, 1.005-1.028; P=0.014), EuroSCORE II (OR, 1.049; 95% CI, 1.004-1.096; P=0.033), and no intake of calcium-channel blockers (CCB) (OR, 4.892; 95% CI, 1.496-16.025; P=0.022) as risk factors for AKI. These risk factors were included in a model to predict postoperative AKI with an area under a receiver operating characteristic curve of 0.783±0.036 (95% CI, 0.713-0.854; P<0.0001). Age, hypertension, low EF, eGFR, EuroSCORE II, and no intake of CCB were independent risk factors for postoperative AKI. These factors provide an easy and accurate model to predict postoperative AKI in patients undergoing cardiac surgery.